Skip to main content
Top
Published in: Cardiovascular Ultrasound 1/2009

Open Access 01-12-2009 | Research

Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients

Authors: Alessandro Salustri, Elena Cerquetani, Mara Piccoli, Guglielmo Pastena, Alfredo Posteraro, Elisabetta Amici, Salvatore La Carrubba, Sherif Bakir, Wael Abdulrahman Al Mahmeed

Published in: Cardiovascular Ultrasound | Issue 1/2009

Login to get access

Abstract

Background

B-type natriuretic peptide (BNP) is increased in post-cardiac surgery patients, however the mechanisms underlying BNP release are still unclear. In the current study, we aimed to assess the relationship between postoperative BNP levels and left ventricular filling pressures in post-cardiac surgery patients.

Methods

We prospectively enrolled 134 consecutive patients referred to our Center 8 ± 5 days after cardiac surgery. BNP was sampled at hospital admission and related to the following echocardiographic parameters: left ventricular (LV) diastolic volume (DV), LV systolic volume (SV), LV ejection fraction (EF), LV mass, relative wall thickness (RWT), indexed left atrial volume (iLAV), mitral inflow E/A ratio, mitral E wave deceleration time (DT), ratio of the transmitral E wave to the Doppler tissue early mitral annulus velocity (E/E').

Results

A total of 124 patients had both BNP and echocardiographic data. The BNP values were significantly elevated (mean 353 ± 356 pg/ml), with normal value in only 17 patients (13.7%). Mean LVEF was 59 ± 10% (LVEF ≥50% in 108 pts). There was no relationship between BNP and LVEF (p = 0.11), LVDV (p = 0.88), LVSV (p = 0.50), E/A (p = 0.77), DT (p = 0.33) or RWT (p = 0.50). In contrast, BNP was directly related to E/E' (p < 0.001), LV mass (p = 0.006) and iLAV (p = 0.026). At multivariable regression analysis, age and E/E' were the only independent predictors of BNP levels.

Conclusion

In post-cardiac surgery patients with overall preserved LV systolic function, the significant increase in BNP levels is related to E/E', an echocardiographic parameter of elevated LV filling pressures which indicates left atrial pressure as a major determinant in BNP release in this clinical setting.
Appendix
Available only for authorised users
Literature
1.
go back to reference Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel AS: Utility of a rapid B-natriuretic peptide (BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002, 9: 202-9.CrossRef Morrison LK, Harrison A, Krishnaswamy P, Kazanegra R, Clopton P, Maisel AS: Utility of a rapid B-natriuretic peptide (BNP) assay in differentiating CHF from lung disease in patients presenting with dyspnea. J Am Coll Cardiol 2002, 9: 202-9.CrossRef
2.
go back to reference Wei T, Zeng C, Chen L, Chen Q, Zhao R, Lu G, Lu C, Wang L: Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail 2005, 7: 75-79.CrossRefPubMed Wei T, Zeng C, Chen L, Chen Q, Zhao R, Lu G, Lu C, Wang L: Bedside tests of B-type natriuretic peptide in the diagnosis of left ventricular diastolic dysfunction in hypertensive patients. Eur J Heart Fail 2005, 7: 75-79.CrossRefPubMed
3.
go back to reference De Lemos JA, Morrow DA: Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes. Am Heart J 2007, 153: 450-3.CrossRefPubMed De Lemos JA, Morrow DA: Use of natriuretic peptides in clinical decision-making for patients with non-ST-elevation acute coronary syndromes. Am Heart J 2007, 153: 450-3.CrossRefPubMed
4.
go back to reference Mair J, Friendl W, Thomas S, Puschendorf B: Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl 1999, 230: 132-42.CrossRefPubMed Mair J, Friendl W, Thomas S, Puschendorf B: Natriuretic peptides in assessment of left-ventricular dysfunction. Scand J Clin Lab Invest Suppl 1999, 230: 132-42.CrossRefPubMed
5.
go back to reference Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105: 595-601.CrossRefPubMed Lubien E, DeMaria A, Krishnaswamy P, Clopton P, Koon J, Kazanegra R, Gardetto N, Wanner E, Maisel AS: Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings. Circulation 2002, 105: 595-601.CrossRefPubMed
6.
go back to reference Yu CM, Sanderson JE, Shum IO, Chan S, Yeung LY, Hung YT, Cockram CS, Woo KS: Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996, 17: 1694-702.CrossRefPubMed Yu CM, Sanderson JE, Shum IO, Chan S, Yeung LY, Hung YT, Cockram CS, Woo KS: Diastolic dysfunction and natriuretic peptides in systolic heart failure. Higher ANP and BNP levels are associated with the restrictive filling pattern. Eur Heart J 1996, 17: 1694-702.CrossRefPubMed
7.
go back to reference Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U: Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002, 40: 718-22.CrossRefPubMed Kruger S, Graf J, Kunz D, Stickel T, Hanrath P, Janssens U: Brain natriuretic peptide levels predict functional capacity in patients with chronic heart failure. J Am Coll Cardiol 2002, 40: 718-22.CrossRefPubMed
8.
go back to reference Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004, 43: 1873-9.CrossRefPubMed Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol 2004, 43: 1873-9.CrossRefPubMed
9.
go back to reference Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, Tønnessen T: The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year follow-up. Eur J Heart Fail 2006, 8: 257-262.CrossRefPubMed Neverdal NO, Knudsen CW, Husebye T, Vengen OA, Pepper J, Lie M, Tønnessen T: The effect of aortic valve replacement on plasma B-type natriuretic peptide in patients with severe aortic stenosis - one year follow-up. Eur J Heart Fail 2006, 8: 257-262.CrossRefPubMed
10.
go back to reference Avidan MS, Meehan N, Ponte J, El-Gamel A, Sherwood RA: Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic arrest. Clin Chim Acta 2001, 303: 127-32.CrossRefPubMed Avidan MS, Meehan N, Ponte J, El-Gamel A, Sherwood RA: Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic arrest. Clin Chim Acta 2001, 303: 127-32.CrossRefPubMed
11.
go back to reference Rawlins ML, Owen WE, Roberts WL: Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 2005, 123: 439-45.CrossRefPubMed Rawlins ML, Owen WE, Roberts WL: Performance characteristics of four automated natriuretic peptide assays. Am J Clin Pathol 2005, 123: 439-45.CrossRefPubMed
12.
go back to reference Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W, American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association, European Association of Echocardiography, European Society of Cardiology: Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7: 79-108.CrossRefPubMed Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise J, Solomon S, Spencer KT, St John Sutton M, Stewart W, American Society of Echocardiography's Nomenclature and Standards Committee; Task Force on Chamber Quantification; American College of Cardiology Echocardiography Committee; American Heart Association, European Association of Echocardiography, European Society of Cardiology: Recommendations for chamber quantification. Eur J Echocardiogr 2006, 7: 79-108.CrossRefPubMed
13.
go back to reference Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ: Clinical utility of Doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressure. Circulation 2000, 102: 1788-1794.CrossRefPubMed Ommen SR, Nishimura RA, Appleton CP, Miller FA, Oh JK, Redfield MM, Tajik AJ: Clinical utility of Doppler echocardiography and tissue doppler imaging in the estimation of left ventricular filling pressure. Circulation 2000, 102: 1788-1794.CrossRefPubMed
14.
go back to reference Kerbaul F, Collart F, Giorgi R, Oddoze C, Lejeune PJ, Guidon C, Caus T, Bellezza M, Gouin F: Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Intensive Care Med 2004, 30: 1799-806.CrossRefPubMed Kerbaul F, Collart F, Giorgi R, Oddoze C, Lejeune PJ, Guidon C, Caus T, Bellezza M, Gouin F: Increased plasma levels of pro-brain natriuretic peptide in patients with cardiovascular complications following off-pump coronary artery surgery. Intensive Care Med 2004, 30: 1799-806.CrossRefPubMed
15.
go back to reference Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, Scheld HH, Brodner G, Walter M: A-type and B-type natriuretic peptide in cardiac surgical procedures. Anesth Analg 2004, 98: 11-9.CrossRefPubMed Berendes E, Schmidt C, Van Aken H, Hartlage MG, Rothenburger M, Wirtz S, Scheld HH, Brodner G, Walter M: A-type and B-type natriuretic peptide in cardiac surgical procedures. Anesth Analg 2004, 98: 11-9.CrossRefPubMed
16.
go back to reference Georges A, Forestier F, Valli N, Plogin A, Janvier G, Bordenave L: Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur Cardiothorac Surg 2004, 25: 941-5.CrossRef Georges A, Forestier F, Valli N, Plogin A, Janvier G, Bordenave L: Changes in type B natriuretic peptide (BNP) concentrations during cardiac valve replacement. Eur Cardiothorac Surg 2004, 25: 941-5.CrossRef
17.
go back to reference Muders F, Kromer EP, Griese DP, Pfeifer M, Hense HW, Riegger GA, Elsner D: Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 1997, 134: 442-9.CrossRefPubMed Muders F, Kromer EP, Griese DP, Pfeifer M, Hense HW, Riegger GA, Elsner D: Evaluation of plasma natriuretic peptides as markers for left ventricular dysfunction. Am Heart J 1997, 134: 442-9.CrossRefPubMed
18.
go back to reference Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H: BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008, 10: 252-259.CrossRefPubMed Grewal J, McKelvie R, Lonn E, Tait P, Carlsson J, Gianni M, Jarnert C, Persson H: BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction. Eur J Heart Fail 2008, 10: 252-259.CrossRefPubMed
19.
go back to reference Douglas PS: The left atrium. A biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 2003, 42: 1206-7.CrossRefPubMed Douglas PS: The left atrium. A biomarker of chronic diastolic dysfunction and cardiovascular disease risk. J Am Coll Cardiol 2003, 42: 1206-7.CrossRefPubMed
20.
go back to reference Dong SJ, de las Fuentes L, Brown AL, Waggoner AD, Ewald GA, Davila-Roman VG: N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort. J Am Soc Echocardiogr 2006, 19: 1017-25.CrossRefPubMed Dong SJ, de las Fuentes L, Brown AL, Waggoner AD, Ewald GA, Davila-Roman VG: N-terminal pro B-type natriuretic peptide levels: correlation with echocardiographically determined left ventricular diastolic function in an ambulatory cohort. J Am Soc Echocardiogr 2006, 19: 1017-25.CrossRefPubMed
21.
go back to reference Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, Yandle TG, Richards AM, Starling RC, Young JB, Thomas JD, Klein AL: Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004, 43: 416-22.CrossRefPubMed Troughton RW, Prior DL, Pereira JJ, Martin M, Fogarty A, Morehead A, Yandle TG, Richards AM, Starling RC, Young JB, Thomas JD, Klein AL: Plasma B-type natriuretic peptide levels in systolic heart failure: importance of left ventricular diastolic function and right ventricular systolic function. J Am Coll Cardiol 2004, 43: 416-22.CrossRefPubMed
22.
go back to reference Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002, 40: 976-82.CrossRefPubMed Redfield MM, Rodeheffer RJ, Jacobsen SJ, Mahoney DW, Bailey KR, Burnett JC Jr: Plasma brain natriuretic peptide concentration: impact of age and gender. J Am Coll Cardiol 2002, 40: 976-82.CrossRefPubMed
23.
go back to reference Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, Bellanuova I, Tripepi R, Seminara G, Parlongo S, Stancanelli B, Bonanno G, Fatuzzo P, Rapisarda F, Belluardo P, Signorelli SS, Heublein DM, Lainchbury JG, Leskinen HK, Bailey KR, Redfield MM, Burnett JC Jr: Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001, 76: 1111-9.CrossRefPubMed Cataliotti A, Malatino LS, Jougasaki M, Zoccali C, Castellino P, Giacone G, Bellanuova I, Tripepi R, Seminara G, Parlongo S, Stancanelli B, Bonanno G, Fatuzzo P, Rapisarda F, Belluardo P, Signorelli SS, Heublein DM, Lainchbury JG, Leskinen HK, Bailey KR, Redfield MM, Burnett JC Jr: Circulating natriuretic peptide concentrations in patients with end-stage renal disease: role of brain natriuretic peptide as a biomarker for ventricular remodeling. Mayo Clin Proc 2001, 76: 1111-9.CrossRefPubMed
Metadata
Title
Relationship between B-type natriuretic peptide levels and echocardiographic indices of left ventricular filling pressures in post-cardiac surgery patients
Authors
Alessandro Salustri
Elena Cerquetani
Mara Piccoli
Guglielmo Pastena
Alfredo Posteraro
Elisabetta Amici
Salvatore La Carrubba
Sherif Bakir
Wael Abdulrahman Al Mahmeed
Publication date
01-12-2009
Publisher
BioMed Central
Published in
Cardiovascular Ultrasound / Issue 1/2009
Electronic ISSN: 1476-7120
DOI
https://doi.org/10.1186/1476-7120-7-49

Other articles of this Issue 1/2009

Cardiovascular Ultrasound 1/2009 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.